Johnson Fistel, LLP investigates potential violations of federal and state laws by certain officers of several publicly traded companies, including DexCom, Inc.

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $90.00. The ...

GET MORE AI-GENERATED SIGNALS: December 03, 2024, 04:18 am ET, BY Chris- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Short DXCM slightly under 86.03, target 68.59, stop loss @ 86.28 ...

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

ModivCare's stock plummeted due to issues with Matrix Medical and delays in contract receivable collections. Read why I ...

They aren't the only kinds of devices that help diabetes patients keep track of their blood glucose levels -- a necessary ...

TCW Select Equities Fund (I Share) generated a net return of +1.41% during the third quarter, underperforming the Russell ...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want ...

Quest Partners LLC lowered its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 64.1% during the 3rd quarter ...

Nvidia partner and data center power and cooling systems maker Vertiv is rebounding from the 21-day moving average into a buy ...

Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Companies aren't ...

Leerink Partners analyst Mike Kratky maintained a Buy rating on Dexcom (DXCM – Research Report) on November 25 and set a price target of ...